Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bone Tumors
Injectable bone graft substitute can fill defects from benign bone tumors
March 22nd, 2004
An injectable calcium sulfate bone graft substitute material can fill defects and promote new bone formation after removal of benign bone tumors. "The treatment of benign bone lesions can be challenging due to the limited quantity of autogenous graft available for harvest and grafting of the defect. The use of a MIIG material for treatment of these bone lesions is advantageous," researchers in the United States report. "Calcium sulfate has a long-standing history in the treatment of bone voids secondary to trauma, infection, or neoplastic processes. MIIG calcium sulfate graft may be injected into surgically created osseous defects or bone defects...
Source: Health & Medicine Week (2004-03-22)
|
